Ukulethwa Okusha Kwe-insulin Okuzenzakalelayo Kwabantu Abanesifo Sikashukela

I-Abbott, i-CamDiab kanye ne-Ypsomed namuhla bamemezele ukuthi bayasebenzisana ukuthuthukisa nokudayisa uhlelo oludidiyelwe oluzenzakalelayo lokulethwa kwe-insulin (AID) ukusiza ukwehlisa umthwalo wokulawulwa kwesifo sikashukela ubusuku nemini kubantu abanesifo sikashukela. Ukugxila kokuqala kobambiswano kuzoba semazweni aseYurophu.              

Uhlelo olusha lwe-AID oludidiyelwe lwenzelwe ukuxhuma inzwa ye-Abbott's FreeStyle Libre® 3, inzwa encane kunazo zonke1 futhi enembe kakhulu emhlabeni wonke2,3 eqhubekayo yokuqapha ushukela efundwa njalo ngomzuzu, nohlelo lokusebenza lweselula lweCamDiab lweCamAPS FX, oluxhuma ne-Ypsomed's mylife™ YpsoPump® - ukudala inqubo ehlakaniphile, ezenzakalelayo yokuletha i-insulin ngokusekelwe kudatha ye-glucose yesikhathi sangempela. Isixazululo esixhumene, esigqokekayo esihlakaniphile siklanyelwe ukugada ngokuqhubekayo amazinga eglucose womuntu futhi silungise ngokuzenzekelayo futhi silethe inani elifanele le-insulin ngesikhathi esifanele, kususe ukuqagela komthamo we-insulin.

“Umgomo wethu uwukwenza ukunakekelwa kwesifo sikashukela kube lula ngangokunokwenzeka, yingakho u-Abbott eqhubeka nokwandisa ithimba lakhe labalingani bokulethwa kwe-insulin, abaqeqeshi bedijithali nabaholi bezobuchwepheshe,” kusho uJared Watkin, iphini likamongameli omkhulu webhizinisi lokunakekelwa kwesifo sikashukela lika-Abbott. “Sifuna ukuletha izixazululo ezintsha ezithuthukile ezenza kube lula futhi zenze abantu bakwazi ukuchitha isikhathi esincane becabanga ngesifo sikashukela kanye nesikhathi esiningi sokuphila.”

“Ukungalawuleki kahle kwe-glucose kubangela ukwanda kwengozi yezinkinga zesifo sikashukela njengokungaboni, nesifo senhliziyo nezinso. Sifuna ukusiza abantu abanesifo sikashukela balawule kangcono i-glucose ngobuchwepheshe obuthuthukisiwe. I-CamAPS FX yethu, esivele igunyaziwe eYurophu, iyi-algorithm evumelana nezimo kakhulu okuthi uma ihlanganiswe nenzwa ka-Abbott iklanyelwe ukuxhumana nephampu ye-insulin ye-Ypsomed ukuze inikeze umthamo ophelele we-insulin, isuse umthwalo wokuphatha isimo esingalawuleki ngokuqhubekayo imini nobusuku. ,” kusho uRoman Hovorka, umqondisi weCamDiab Ltd.

“Siqinisekile ukuthi izinselelo ezinkulu zomphakathi zingaxazululwa kuphela ngokubambisana. Ngakho-ke siyaziqhenya ngokwandisa ozakwethu bethu nokuxhumana ukuze sinikeze inkululeko eyengeziwe yokuzikhethela ekulawuleni isifo sikashukela. Uma kuhlanganiswe i-mylife ™ YpsoPump® yethu nohlelo lwe-FreeStyle Libre 3 kanye nohlelo lokusebenza lwe-CamAPS FX oluthuthukisiwe oluguquguqukayo oluvaliwe, sizokwazi ukuletha uhlelo olwengeziwe lwe-AID oluhlangene nolulula oluhlakaniphile futhi olulula ukulusebenzisa,” kusho uSimon Michel. isikhulu esiphezulu se-Ypsomed.

Izinkampani zihlose ukuqeda intuthuko ekupheleni kuka-2022 nokutholakala kwezohwebo okulindeleke ngemva kwalokho.